+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Specialty PACS Market Size, Share & Industry Trends Analysis Report By Deployment Model, By Type, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), By Country and Growth Forecast, 2021-2027

  • PDF Icon

    Report

  • 99 Pages
  • February 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5570990
The Asia Pacific Specialty PACS Market is expected to witness market growth of 6.7% CAGR during the forecast period (2021-2027).

The PACS serves with the benefits that a patient can go through radiological investigation at one separate location but the images can be accessed by multiple physicians and radiologists from different locations. The PACS technology stores the pictures in the archive and from there, those images can be reviewed on a review station. Furthermore, the increase in medical imaging volumes, the growing awareness of early disease diagnosis and the advancement in specialty PACS are surging demand for specialty PACS technology.

The information collected by the help of PACS systems can be utilized to identify any kind of physiological & anatomical abnormalities. The digital access can be considered as the most updated version of medical imaging. By having the clinical reports and history of the patients’ health condition through the PACS systems, the prescription and the treatment errors can be eliminated, which can enhance the patients’ overall treatment.

Growing GDP, increased spending in the development of healthcare infrastructure by the private as well as government sector, rapid urbanization, and the thriving medical tourism industry also serve as an opportunity for market growth mainly in emerging economies like India and China. Also, the increased demand for PACS systems in the countries like Indonesia and Australia has opened new avenues for the companies' manufacturing PACS systems which is expected to result in the market growth of the Asia Pacific region.

The China market dominated the Asia Pacific Specialty PACS Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $302.6 million by 2027. The Japan market is anticipated to grow a CAGR of 6.1% during (2021 - 2027). Additionally, The India market is expected to experience a CAGR of 7.3% during (2021 - 2027).

Based on Deployment Model, the market is segmented into On premises and Cloud-based. Based on Type, the market is segmented into Radiology PACS, Orthopedics PACS, Oncology PACS, Pathology PACS, Ophthalmology PACS, Women’s health PACS, and Others. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novarad Enterprise Healthcare Solutions, Escalon Medical Corp., IBM Corporation, Siemens AG, Canon, Inc., INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., McKesson Corporation, Carestream Health, Inc., and Topcon Corporation.

Scope of the Study


Market Segments Covered in the Report:


By Deployment Model
  • On premises
  • Cloud-based

By Type
  • Radiology PACS
  • Orthopedics PACS
  • Oncology PACS
  • Pathology PACS
  • Ophthalmology PACS
  • Women’s health PACS
  • Others

By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players


List of Companies Profiled in the Report:


  • Novarad Enterprise Healthcare Solutions
  • Escalon Medical Corp.
  • IBM Corporation
  • Siemens AG
  • Canon, Inc.
  • INFINITT Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Carestream Health, Inc.
  • Topcon Corporation

Unique Offerings from the Publisher


  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Specialty PACS Market, by Deployment Model
1.4.2 Asia Pacific Specialty PACS Market, by Type
1.4.3 Asia Pacific Specialty PACS Market, by End User
1.4.4 Asia Pacific Specialty PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnership, Collaborations and Agreements: 2017, Jul – 2022, Jan) Leading Players
Chapter 4. Asia Pacific Specialty PACS Market by Deployment Model
4.1 Asia Pacific On premises Market by Country
4.2 Asia Pacific Cloud-based Market by Country
Chapter 5. Asia Pacific Specialty PACS Market by Type
5.1 Asia Pacific Radiology PACS Market by Country
5.2 Asia Pacific Orthopedics PACS Market by Country
5.3 Asia Pacific Oncology PACS Market by Country
5.4 Asia Pacific Pathology PACS Market by Country
5.5 Asia Pacific Ophthalmology PACS Market by Country
5.6 Asia Pacific Women’s health PACS Market by Country
5.7 Asia Pacific Other Type Market by Country
Chapter 6. Asia Pacific Specialty PACS Market by End User
6.1 Asia Pacific Hospitals & Clinics Market by Country
6.2 Asia Pacific Ambulatory Surgical Centers Market by Country
6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Specialty PACS Market by Country
7.1 China Specialty PACS Market
7.1.1 China Specialty PACS Market by Deployment Model
7.1.2 China Specialty PACS Market by Type
7.1.3 China Specialty PACS Market by End User
7.2 Japan Specialty PACS Market
7.2.1 Japan Specialty PACS Market by Deployment Model
7.2.2 Japan Specialty PACS Market by Type
7.2.3 Japan Specialty PACS Market by End User
7.3 India Specialty PACS Market
7.3.1 India Specialty PACS Market by Deployment Model
7.3.2 India Specialty PACS Market by Type
7.3.3 India Specialty PACS Market by End User
7.4 South Korea Specialty PACS Market
7.4.1 South Korea Specialty PACS Market by Deployment Model
7.4.2 South Korea Specialty PACS Market by Type
7.4.3 South Korea Specialty PACS Market by End User
7.5 Singapore Specialty PACS Market
7.5.1 Singapore Specialty PACS Market by Deployment Model
7.5.2 Singapore Specialty PACS Market by Type
7.5.3 Singapore Specialty PACS Market by End User
7.6 Malaysia Specialty PACS Market
7.6.1 Malaysia Specialty PACS Market by Deployment Model
7.6.2 Malaysia Specialty PACS Market by Type
7.6.3 Malaysia Specialty PACS Market by End User
7.7 Rest of Asia Pacific Specialty PACS Market
7.7.1 Rest of Asia Pacific Specialty PACS Market by Deployment Model
7.7.2 Rest of Asia Pacific Specialty PACS Market by Type
7.7.3 Rest of Asia Pacific Specialty PACS Market by End User
Chapter 8. Company Profiles
8.1 Novarad Enterprise Healthcare Solutions
8.1.1 Company Overview
8.1.2 Recent Strategies and developments:
8.1.2.1 Partnerships, Collaborations and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.2 Escalon Medical Corp.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent Strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Siemens AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent Strategies and developments:
8.4.5.1 Partnerships, Collaborations and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisitions and Mergers:
8.4.6 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent Strategies and developments:
8.5.5.1 Partnerships, Collaborations and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 INFINITT Healthcare Co. Ltd.
8.6.1 Company Overview
8.6.2 Recent Strategies and developments:
8.6.2.1 Partnerships, Collaborations and Agreements:
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisitions and Mergers:
8.8 McKesson Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Carestream Health, Inc. (Onex Corporation)
8.9.1 Company Overview
8.10. Topcon Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Recent Strategies and developments:
8.10.4.1 Partnerships, Collaborations and Agreements:
8.10.4.2 Acquisitions and Mergers:

Companies Mentioned

  • Novarad Enterprise Healthcare Solutions
  • Escalon Medical Corp.
  • IBM Corporation
  • Siemens AG
  • Canon, Inc.
  • INFINITT Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Carestream Health, Inc.
  • Topcon Corporation

Methodology

Loading
LOADING...